Ischemia Reperfusion Injury Therapeutics Market Report

Global and Region Ischemia Reperfusion Injury Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：217
  • REPORT CODE：GMM923688
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Ischemia Reperfusion Injury Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Ischemia Reperfusion Injury Therapeuticsmarket, defines the market attractiveness level of Ischemia Reperfusion Injury Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Ischemia Reperfusion Injury Therapeutics industry, describes the types of Ischemia Reperfusion Injury Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ischemia Reperfusion Injury Therapeutics market and the development prospects and opportunities of Ischemia Reperfusion Injury Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ischemia Reperfusion Injury Therapeutics market in Chapter 13.

    By Player:

    • Antipodean Pharmaceuticals, Inc

    • Bayer AG

    • Bolder Biotechnology, Inc

    • Pharming Group NV

    • Stealth BioTherapeutics Inc

    • Ensemble Therapeutics Corporation

    • Biomedica Management Corporation

    • PledPharma AB

    • Zealand Pharma A/S

    • Prolong Pharmaceuticals

    • Orexo AB

    • Erimos Pharmaceuticals, LLC

    • Curatis Pharma GmbH

    • Prothix BV

    • Omeros Corporation

    • Nyken BV

    • Opsona Therapeutics Limited

    • Angion Biomedica Corp

    • Gilead Sciences, Inc

    • Amyndas Pharmaceuticals LLC

    • Proteo, Inc

    By Type:

    • Heart Injury

    • Kidney Injury

    • Intestine Injury

    • Other Injury

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Ischemia Reperfusion Injury Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Ischemia Reperfusion Injury Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Ischemia Reperfusion Injury Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Ischemia Reperfusion Injury Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Ischemia Reperfusion Injury Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    • 7.2 United States Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    • 7.3 Europe Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    • 7.4 China Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    • 7.5 Japan Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    • 7.6 India Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Ischemia Reperfusion Injury Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Ischemia Reperfusion Injury Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Ischemia Reperfusion Injury Therapeutics Consumption Forecast (2022-2028)

    9 Global Ischemia Reperfusion Injury Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Heart Injury Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Kidney Injury Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Intestine Injury Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Injury Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Ischemia Reperfusion Injury Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Heart Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Kidney Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Intestine Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Injury Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Ischemia Reperfusion Injury Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Ischemia Reperfusion Injury Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Ischemia Reperfusion Injury Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Ischemia Reperfusion Injury Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Ischemia Reperfusion Injury Therapeutics Market Competitive Analysis

    • 14.1 Antipodean Pharmaceuticals, Inc

      • 14.1.1 Antipodean Pharmaceuticals, Inc Company Details

      • 14.1.2 Antipodean Pharmaceuticals, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Antipodean Pharmaceuticals, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.2 Bayer AG

      • 14.2.1 Bayer AG Company Details

      • 14.2.2 Bayer AG Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer AG Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.3 Bolder Biotechnology, Inc

      • 14.3.1 Bolder Biotechnology, Inc Company Details

      • 14.3.2 Bolder Biotechnology, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bolder Biotechnology, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.4 Pharming Group NV

      • 14.4.1 Pharming Group NV Company Details

      • 14.4.2 Pharming Group NV Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pharming Group NV Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.5 Stealth BioTherapeutics Inc

      • 14.5.1 Stealth BioTherapeutics Inc Company Details

      • 14.5.2 Stealth BioTherapeutics Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Stealth BioTherapeutics Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.6 Ensemble Therapeutics Corporation

      • 14.6.1 Ensemble Therapeutics Corporation Company Details

      • 14.6.2 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.7 Biomedica Management Corporation

      • 14.7.1 Biomedica Management Corporation Company Details

      • 14.7.2 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.8 PledPharma AB

      • 14.8.1 PledPharma AB Company Details

      • 14.8.2 PledPharma AB Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 PledPharma AB Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.9 Zealand Pharma A/S

      • 14.9.1 Zealand Pharma A/S Company Details

      • 14.9.2 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.10 Prolong Pharmaceuticals

      • 14.10.1 Prolong Pharmaceuticals Company Details

      • 14.10.2 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.11 Orexo AB

      • 14.11.1 Orexo AB Company Details

      • 14.11.2 Orexo AB Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Orexo AB Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.12 Erimos Pharmaceuticals, LLC

      • 14.12.1 Erimos Pharmaceuticals, LLC Company Details

      • 14.12.2 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.13 Curatis Pharma GmbH

      • 14.13.1 Curatis Pharma GmbH Company Details

      • 14.13.2 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.14 Prothix BV

      • 14.14.1 Prothix BV Company Details

      • 14.14.2 Prothix BV Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Prothix BV Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.15 Omeros Corporation

      • 14.15.1 Omeros Corporation Company Details

      • 14.15.2 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.16 Nyken BV

      • 14.16.1 Nyken BV Company Details

      • 14.16.2 Nyken BV Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Nyken BV Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.17 Opsona Therapeutics Limited

      • 14.17.1 Opsona Therapeutics Limited Company Details

      • 14.17.2 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.18 Angion Biomedica Corp

      • 14.18.1 Angion Biomedica Corp Company Details

      • 14.18.2 Angion Biomedica Corp Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Angion Biomedica Corp Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.19 Gilead Sciences, Inc

      • 14.19.1 Gilead Sciences, Inc Company Details

      • 14.19.2 Gilead Sciences, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Gilead Sciences, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.20 Amyndas Pharmaceuticals LLC

      • 14.20.1 Amyndas Pharmaceuticals LLC Company Details

      • 14.20.2 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Product and Service

    • 14.21 Proteo, Inc

      • 14.21.1 Proteo, Inc Company Details

      • 14.21.2 Proteo, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Proteo, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Ischemia Reperfusion Injury Therapeutics

    • Figure Ischemia Reperfusion Injury Therapeutics Picture

    • Table Global Ischemia Reperfusion Injury Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ischemia Reperfusion Injury Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ischemia Reperfusion Injury Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Ischemia Reperfusion Injury Therapeutics Consumption by Country (2017-2022)

    • Figure United States Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ischemia Reperfusion Injury Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Ischemia Reperfusion Injury Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ischemia Reperfusion Injury Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Intestine Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Other Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intestine Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Ischemia Reperfusion Injury Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Ischemia Reperfusion Injury Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Antipodean Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Antipodean Pharmaceuticals, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Antipodean Pharmaceuticals, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Bolder Biotechnology, Inc (Foundation Year, Company Profile and etc.)

    • Table Bolder Biotechnology, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bolder Biotechnology, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Pharming Group NV (Foundation Year, Company Profile and etc.)

    • Table Pharming Group NV Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharming Group NV Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Stealth BioTherapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Stealth BioTherapeutics Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stealth BioTherapeutics Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Ensemble Therapeutics Corporation (Foundation Year, Company Profile and etc.)

    • Table Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Biomedica Management Corporation (Foundation Year, Company Profile and etc.)

    • Table Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table PledPharma AB (Foundation Year, Company Profile and etc.)

    • Table PledPharma AB Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table PledPharma AB Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Zealand Pharma A/S (Foundation Year, Company Profile and etc.)

    • Table Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Prolong Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Orexo AB (Foundation Year, Company Profile and etc.)

    • Table Orexo AB Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orexo AB Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Erimos Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)

    • Table Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Curatis Pharma GmbH (Foundation Year, Company Profile and etc.)

    • Table Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Prothix BV (Foundation Year, Company Profile and etc.)

    • Table Prothix BV Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prothix BV Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Omeros Corporation (Foundation Year, Company Profile and etc.)

    • Table Omeros Corporation Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omeros Corporation Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Nyken BV (Foundation Year, Company Profile and etc.)

    • Table Nyken BV Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nyken BV Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Opsona Therapeutics Limited (Foundation Year, Company Profile and etc.)

    • Table Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Angion Biomedica Corp (Foundation Year, Company Profile and etc.)

    • Table Angion Biomedica Corp Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Angion Biomedica Corp Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences, Inc Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Amyndas Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)

    • Table Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Product and Service

    • Table Proteo, Inc (Foundation Year, Company Profile and etc.)

    • Table Proteo, Inc Ischemia Reperfusion Injury Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Proteo, Inc Ischemia Reperfusion Injury Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US